AGENUS INC — Director's Dealing 2021

Apr 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2021-04-02

Reporting Person: KLASKIN CHRISTINE M (PFO & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-02	Common Stock	A	24278	$2.87	Acquired	88611	Direct

Footnotes

F1: All Agenus employees were given the option to receive their 2020 bonus awards in cash or Agenus stock. Dr. Armen, Dr. Buell and Ms. Klaskin have all chosen to receive their entire 2020 bonus award in Agenus stock rather than cash. The stock issued is fully-vested on the date of issuance, but is subject to a 6-month lockup restriction.

F2: $2.87 is the fair market value of our Common Stock on April 2, 2021, the stock issuance date.